stockrowBiorestorative Therapies, Inc. (BRTX) vs VivoSim Labs, Inc. (VIVS)
- Biorestorative Therapies, Inc. BRTX 1.48 −1.99%
- VivoSim Labs, Inc. VIVS 0.14 0.00%
Biorestorative Therapies, Inc. and VivoSim Labs, Inc. are both Biotechnology companies. VivoSim Labs, Inc. is the larger, with a market value of $2.3M against $2.1M — 1.1× the size. Biorestorative Therapies, Inc. grew revenue faster over the last twelve months: −8.47% against −21.1%. Biorestorative Therapies, Inc. has the higher net margin (−3,089.3% vs −11,016.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Biorestorative Therapies, Inc. leads on 11 and VivoSim Labs, Inc. on 5.
Valuation
Profitability
| Metric | BRTX | VIVS | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.09% | 100.00% | 68.51% |
| Operating margin | (3,974.66%) | (10,116.96%) | 0.00% |
| Net margin | (3,089.30%) | (11,016.07%) | 0.00% |
| Free cash flow margin | (3,302.04%) | (1,014.29%) | 0.00% |
| Return on equity | (241.50%) | (343.10%) | (51.96%) |
| Return on assets | (147.75%) | (155.93%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack